Henrik Kaessmann: Grand-scale genetics

Credit: © SEAN MACLEOD PHOTOGRAPHY" /> Credit: © SEAN MACLEOD PHOTOGRAPHY Henrik Kaessmann is not a trained bioinformaticist. He acquired his computational skills after his PhD, on the road to uncovering the subtleties of gene origin and function, with many of his projects operating on a grand scale. Over the short evolution of his career, however, he has become one of the world's foremost bioinformatics researchers. Kaessmann's first large-scale project was during his

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Henrik Kaessmann is not a trained bioinformaticist. He acquired his computational skills after his PhD, on the road to uncovering the subtleties of gene origin and function, with many of his projects operating on a grand scale. Over the short evolution of his career, however, he has become one of the world's foremost bioinformatics researchers.

Kaessmann's first large-scale project was during his PhD at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, under evolutionary geneticist, Svante Paabo. "When he first applied to be a grad student I actually turned him down; there was no space," Paabo says, "but he persisted and came back after a few months. He turned out to be one of the absolutely best students I've ever had."

At the Planck Institute, Kaessmann did groundbreaking work on mitochondrial genome variation and the origin of modern humans.1 He sequenced the entire mitochondrial genome - 60,000 base ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies